Qube Research & Technologies LTD Talis Biomedical Corp Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $699 - $10,779	-999 Reduced 9.03%	10,059 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $29,491 - $52,428	-36,409 Reduced 76.7%	11,058 $9,000
Q1 2022 May 09, 2022	SELL	$1.3 - $4.19 $15,202 - $48,997	-11,694 Reduced 19.77%	47,467 $67,000
Q4 2021 Feb 01, 2022	BUY	$3.81 - $6.17 $136,638 - $221,274	35,863 Added 153.93%	59,161 $237,000
Q3 2021 Nov 12, 2021	BUY	$6.02 - $12.46 $140,253 - $290,293	23,298 New	23,298 $146,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.